Aashutosh Shetti

Aashutosh Shetti

Auto-generated profile, based on publicly available information

Aashutosh Shetti

Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
RMRachana Mishra
Rachana Mishra
TPTrongha Phan
Trongha Phan
Pavan KumarPavan Kumar
Pavan Kumar
ZMZachery Morrissey
Zachery Morrissey
MGMuskan Gupta
Muskan Gupta
OLOrly Lazarov
Orly Lazarov
Hippocampal neurogenesis is impaired in Alzheimer’s disease (AD) patients and familial Alzheimer’s disease (FAD) mouse models. However, it is unknown whether new neurons play a causative role in memory deficits. Here, we show that immature neurons were actively recruited into the engram following a hippocampus-dependent task. However, their recruitment is severely deficient in FAD. Recruited immature neurons exhibited compromised spine density and altered transcript profile. Targeted augmentation of neurogenesis in FAD mice restored the number of new neurons in the engram, the dendritic spine density, and the transcription signature of both immature and mature neurons, ultimately leading to the rescue of memory. Chemogenetic inactivation of immature neurons following enhanced neurogenesis in AD, reversed mouse performance, and diminished memory. Notably, AD-linked App, ApoE, and Adam10 were of the top differentially expressed genes in the engram. Collectively, these observations suggest that defective neurogenesis contributes to memory failure in AD.

3 February 2023 in Brain
Verified
Journal Article
Open access
PDF file
ASAashutosh U Shetti
Aashutosh U Shetti
ARAbhirami Ramakrishnan
Abhirami Ramakrishnan
LRLiudmila Romanova
Liudmila Romanova
WLWenping Li
Wenping Li
KVKhanh Vo
Khanh Vo
OLOrly Lazarov
Orly Lazarov
Patients with type 2 diabetes exhibit severe impairments in insulin signaling in the brain and are 5-times more likely to develop Alzheimer’s disease. However, what leads to these impairments is not fully understood. Here, we show reduced expression of endothelial cell caveolin-1 (Cav-1) in the db/db (Leprdb) mouse model of type-2 diabetes. This reduction correlated with alterations in insulin receptor expression and signaling in brain microvessels as well as brain parenchyma. These findings were recapitulated in the brains of endothelial cell-specific Cav-1 knock-out (Tie2Cre; Cav-1fl/fl) mice. Lack of Cav-1 in endothelial cells led to reduced response to insulin as well as reduced insulin uptake. Furthermore, we observed that Cav-1 was necessary for the stabilization of insulin receptors in lipid rafts. Interactome analysis revealed the insulin receptor interacts with Cav-1 and caveolae-associated proteins, insulin degrading enzyme, and the tight junction protein Zonula Occludence-1 in brain endothelial cells. Restoration of Cav-1 in Cav-1 knockout brain endothelial cells rescued insulin receptor expression and localization. Overall, these results suggest that Cav-1 regulates insulin signaling and uptake by brain endothelial cells by regulating IR-a and IR-b localization and function in lipid rafts. Furthermore, depletion of endothelial cell specific Cav-1 and the resulting impairment in insulin transport leads to alteration in insulin signaling in the brain parenchyma of type 2 diabetes.

14 April 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
RHRobert Harmon
Robert Harmon
EMErin McCarthy
Erin McCarthy
AKAnnette Krol
Annette Krol
JBJonas Braun
Jonas Braun
ASAashutosh Shetti
Aashutosh Shetti
KGKathleen Green
Kathleen Green
Disorders linked to heterozygous variants occupy a continuum in terms of the timing and severity of phenotypic emergence. An important question regarding this variability entails the effect stress has on the residual protein function. Using Darier disease (DD), caused by heterozygous variants of the SERCA2 calcium pump, as a model, we uncovered a potential connection between extrinsic stress and pathogenesis. The skin lesions characteristic of DD entail loss of intercellular adhesion and rarely appear pre-adolescence, suggesting that factors beyond heterozygosity contribute to disease pathogenesis. Testing whether age-related stressors contribute to DD, we show that DD patient-derived keratinocytes subjected to stress yield twice the reactive oxygen species of controls, accompanied by greater disruption of intercellular adhesion. Metabolic analysis of DD cells revealed perturbation of the pentose phosphate pathway (PPP), a stress response system responsible for regenerating antioxidants like glutathione. At baseline, DD cells had less free glutathione but an increase in protective glutathione-based modifications of SERCA2, a reversible form of protein oxidation. With stress, DD cells form an aberrant, heavily glutathionylated perinuclear halo consisting of keratin and the intercellular adhesion component, desmoplakin. We propose a model whereby SERCA2 heterozygosity causes mild oxidative stress that under homeostatic conditions can be buffered by glutathionylation. When stressed, the depleted glutathione store is shunted towards the desmoplakin-intermediate filament system at the expense of SERCA2, rendering it vulnerable to damage. A lesional flare, then, would represent a case of more complete SERCA2 inhibition and a novel example of how heterozygous disorders interact with stress to disrupt intercellular adhesion.

7 August 2026 in Science Advances
Verified
Journal Article
Closed access
RHRobert M. Harmon
Robert M. Harmon
EMErin F. McCarthy
Erin F. McCarthy
AKAnnette Krol
Annette Krol
ASAashutosh Shetti
Aashutosh Shetti
JBJonas Braun
Jonas Braun
KGKathleen J. Green
Kathleen J. Green
Congenital pathogenic gene variants may not elicit symptoms until later in life, highlighting the importance of identifying extra-genetic factors influencing the onset and severity of heritable diseases. We explored this in Darier disease (DD or ATP2A2 -nEDD), an autosomal dominant skin disorder arising from heterozygous ATP2A2 variants leading to haploinsufficiency of the endoplasmic reticulum (ER) calcium pump, SERCA2. Metabolic analysis of epidermal keratinocytes from confirmed patients with DD revealed abnormalities in the pentose phosphate pathway responsible for regenerating antioxidants like glutathione, accompanied by diminished free glutathione and increased glutathione-based, oxidative modifications of SERCA2. Induction of oxidative stress weakened intercellular adhesion, a defining characteristic of DD, which antioxidant treatment improved. Treatment with antioxidants or SERCA activators also diminished glutathionylation, consistent with SERCA2 haploinsufficiency giving rise to oxidative stress and placing residual SERCA2 at risk of oxidation. We posit that partial loss of protein activity primes cells for stress-induced loss of the remaining activity, a mechanism that may drive disease flares in other haploinsufficiencies.